Trials / Completed
CompletedNCT03385382
Ranibizumab Versus Dexamethasone Implant in Diabetic Macular Edema
Macular Thickness and Vessel Density Changes After Dexamethasone Implant and Ranibizumab Intravitreal Injection in Diabetic Macular Edema: 6-month Follow-up
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 40 (actual)
- Sponsor
- G. d'Annunzio University · Academic / Other
- Sex
- All
- Age
- 19 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
Between December 2016 and June 2017 a total of 40 eyes from 40 diabetic retinopathy patients with diabetic macular edema were recruited at the Ophthalmologic Clinic of University "G. d'Annunzio", Chieti-Pescara, Italy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dexamethasone intravitreal implant 0.7 mg | Intravitreal Implant of dexamethasone |
| DRUG | Ranibizumab Injection | Injection of ranibizumab |
Timeline
- Start date
- 2016-12-06
- Primary completion
- 2017-06-27
- Completion
- 2017-06-27
- First posted
- 2017-12-28
- Last updated
- 2018-01-02
Source: ClinicalTrials.gov record NCT03385382. Inclusion in this directory is not an endorsement.